Clinical TrialsSearch results
Number of results: 761
Other
- A phase II randomized trial in completely resected Non-Small-Cell Lung Cancer comparing paclitaxel / carboplatin with docetaxel / cisplatin TORG0503
- Non-Small-Cell Lung Cancer
- Thoracic Oncology Research Group (TORG)
- 2008-07-11
Recruiting
- JCOG2103: Randomized phase III study comparing systemic therapy and debulking surgery consisting of primary tumor resection with systemic therapy alone for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination
- non-small-cell lung cancer
- WATANABE Shun-ichi
- 2023-02-28
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Recruiting
- JCOG2108: A multicenter randomized phase III study of systemic chemotherapy followed by maintenance therapy versus local consolidation therapy for postoperative oligometastatic recurrent non-small cell lung cancer
- Non-small cell lung cancere
- Watanabe Shun-ichi
- 2023-11-24
Other
- Phase II study of docetaxel, cisplatin, and zoledronic acid for advanced non-small cell lung cancer with bone metastases
- non-small cell lung cancer with bone metastases
- Thoracic Oncology Division, National Cancer Center Hospital East
- 2007-06-07
Recruiting
- A Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
- Non-small cell lung cancer harboring activating EGFR or HER2 kinase domain mutations
- Isui Ayako
- 2022-11-22
Other
- Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer(JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Phase II trial of preoperatively CDDP/S-1 for patients with clinical stage II(exclusion N0 disease) and Stage IIIA non-small cell lung cancer
- Non-small cell lung cancer
- Thoracic Surgery, Graduate School of Medicine, Chiba University
- 2009-05-01
Other
- Feasibility study of TS-1 after surgery with Cisplatin/Docetaxel in completely resected pathological stage II/IIIA non-small cell lung cancer (TORG0809)
- Non-small Cell Lung Cancer
- Thoracic Oncology Research Group (TORG)
- 2009-04-01
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22